ScinoPharm Taiwan Ltd (1789)

Currency in TWD
21.40
+0.40(+1.90%)
Closed·
1789 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
20.9521.45
52 wk Range
16.2529.10
Key Statistics
Bid/Ask
27.10 / 27.15
Prev. Close
21
Open
21.15
Day's Range
20.95-21.45
52 wk Range
16.25-29.1
Volume
786.15K
Average Volume (3m)
1.65M
1-Year Change
17.5824%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
1789 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
18.00
Downside
-15.89%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

ScinoPharm Taiwan Ltd News & Analysis

Show more

ScinoPharm Taiwan, Ltd., a pharmaceutical company, provides active pharmaceutical ingredient (API) development and manufacturing and injectable solutions in Taiwan, rest of Asia, Europe, and the Americas. It offers small molecules, peptide drugs, and steroids; drug products for anticancer, thromboembolic disorders, and osteoporosis; and contract analytical testing, sterile injectables contract manufacturing, and small molecules and peptide contract development and manufacturing organization services. The company was incorporated in 1997 and is headquartered in Tainan City, Taiwan.

Employees
540
Market
Taiwan

Compare 1789 to Peers and Sector

Metrics to compare
1789
Peers
Sector
Relationship
P/E Ratio
121.3x34.6x−0.5x
PEG Ratio
−2.010.520.00
Price/Book
1.6x3.5x2.6x
Price / LTM Sales
5.2x5.6x3.2x
Upside (Analyst Target)
−14.3%26.4%45.2%
Fair Value Upside
Unlock11.5%6.4%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 18.00
(-15.89% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.17%
Dividend Yield
1.67%
Industry Median 2.37%
Annualised payout
0.35
Paid annually
5-Years Growth
-10.32%
Growth Streak

Earnings

Latest Release
05-03-2026
EPS / Forecast
0.05 / 0.13
Revenue / Forecast
1.01B / 900M
EPS Revisions
Last 90 days

1789 Income Statement

FAQ

What Is the SPT (1789) Share Price Today?

The SPT share price today is 21.40 TWD.

What is the current SPT (1789) share price and day range?

As of 23-04-2026, the SPT share price is 21.40 TWD, with a previous close of 21.00 TWD. The share price has ranged from 20.95 to 21.45 TWD today, while the 52-week range spans from 16.25 to 29.10 TWD.

What Is the SPT Market Cap?

As of today, SPT market cap is 16.61B.

Does SPT Pay Dividends? What's The Current Dividend Yield?

The SPT dividend yield is 1.7%.

What Is the SPT (1789) Share Price Target?

The average 12-month share price target for SPT is 18.00 TWD, with a high estimate of 18 TWD and a low estimate of 18 TWD. 0 analysts recommend buying, while 0 suggest selling, with an overall rating of Neutral and -15.89% Downside potential.

What Is SPT's Earnings Per Share (TTM)?

The SPT EPS (TTM) is 0.17.

When Is the Next SPT Earnings Date?

SPT will release its next earnings report on 13-05-2026.

From a Technical Analysis Perspective, Is 1789 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

What Stock Exchange Does SPT Trade On?

SPT is listed and trades on the Taiwan Stock Exchange.

What Is the Stock Symbol for SPT?

The stock symbol for SPT is "1789."

How Many Times Has SPT Stock Split?

SPT has split 6 times.

How Many Employees Does SPT Have?

SPT has 540 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.